Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Nitric oxide (NO) inhalation has been reported to increase the oxygen affinity of sickle cell erythrocytes. Also, proposed allosteric mechanisms for hemoglobin, based on S-nitrosation of beta-chain cysteine 93, raise the possibility of altering the pathophysiology of sickle cell disease by inhibiting polymerization or by increasing NO delivery to the tissue. We studied the effects of a 2-hour treatment, using varying concentrations of inhaled NO. Oxygen affinity, as measured by P(50), did not respond to inhaled NO, either in controls or in individuals with sickle cell disease. At baseline, the arterial and venous levels of nitrosylated hemoglobin were not significantly different, but NO inhalation led to a dose-dependent increase in mean nitrosylated hemoglobin, and at the highest dosage, a significant arterial-venous difference emerged. The levels of nitrosylated hemoglobin are too low to affect overall hemoglobin oxygen affinity, but augmented NO transport to the microvasculature seems a promising strategy for improving microvascular perfusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin.
Stamler, J. S., Jaraki, O., Osborne, J., Simon, D. I., Keaney, J., Vita, J., Singel, D., Valeri, C. R., & Loscalzo, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7674 · Cited by 1,238
Pathogenesis and Treatment of Sickle Cell Disease
Bunn, H. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371107 · Cited by 1,154 · cited 1×
“Introduction In sickle cell anemia erythrocytes, deoxygenation of sickle hemoglobin (hemoglobin S) leads to intracellular polymer formation, ultimately distorting the erythrocyte and retarding red cell transit through the microvasculature (1).”
BackgroundBlood Flow Regulation by S -Nitrosohemoglobin in the Physiological Oxygen Gradient
Stamler, J. S., Jia, L., Eu, J. P., McMahon, T. J., Demchenko, I. T., Bonaventura, J., Gernert, K., & Piantadosi, C. A. (1997) · Science · doi:10.1126/science.276.5321.2034 · Cited by 1,050
Arnelle, D. R., & Stamler, J. S. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1231 · Cited by 604
Fox-Robichaud, A., Payne, D., Hasan, S. U., Ostrovsky, L., Fairhead, T., Reinhardt, P., & Kubes, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2736 · Cited by 227 · cited 1×
“microvasculature, may modulate vascular tone (6), inhibit platelet activation (18), and inhibit leukocyte Pselectin–dependent adhesion and migration (19).”
Background
Cited by
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Self-citationGladwin, M. T., Shelhamer, J. H., Schechter, A. N., Pease-Fye, M. E., Waclawiw, M. A., Panza, J. A., Ognibene, F. P., & Cannon, R. O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11482 · Cited by 441
Self-citationArginine Therapy: A New Treatment for Pulmonary Hypertension in Sickle Cell Disease?
Morris, C. R., Morris, S. M., Hagar, W., van Warmerdam, J., Claster, S., Kepka-Lenhart, D., Machado, L., Kuypers, F. A., & Vichinsky, E. P. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-967oc · Cited by 329
Pathophysiology and treatment of stroke in sickle-cell disease: present and future
Switzer, J. A., Hess, D. C., Nichols, F. T., & Adams, R. J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70469-0 · Cited by 309
Isenberg, J. S., Martin-Manso, G., Maxhimer, J. B., & Roberts, D. D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2561 · Cited by 305
Cannon, R. O., Schechter, A. N., Panza, J. A., Ognibene, F. P., Pease-Fye, M. E., Waclawiw, M. A., Shelhamer, J. H., & Gladwin, M. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12761 · Cited by 299
Self-citationCannon, R. O., Schechter, A. N., Panza, J. A., Ognibene, F. P., Pease-Fye, M. E., Waclawiw, M. A., Shelhamer, J. H., & Gladwin, M. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112761 · Cited by 298
“Injection of samples into this I3 reductant stoichiometrically produces NO from nitrosothiols (21, 23).”
BackgroundMethodSelf-citationGladwin, M. T., Ognibene, F. P., Pannell, L. K., Nichols, J. S., Pease-Fye, M. E., Shelhamer, J. H., & Schechter, A. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180155397 · Cited by 271
Self-citationRed blood cell magnetophoresis
Zborowski, M., Ostera, G. R., Moore, L. R., Milliron, S., Chalmers, J. J., & Schechter, A. N. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)75069-3 · Cited by 260
“The effects of metHb, however, would be smaller because its production by oxidative processes, especially the interaction with nitric oxide (Gladwin et al., 1999), normally leads to very low levels in the circulation.”
BackgroundSelf-citationMoore, D. F., Scott, L. T. C., Gladwin, M. T., Altarescu, G., Kaneski, C., Suzuki, K., Pease-Fye, M., Ferri, R., Brady, R. O., Herscovitch, P., et al. (2001) · Circulation · doi:10.1161/hc3801.096352 · Cited by 252
Self-citationYang, B. K., Vivas, E. X., Reiter, C. D., & Gladwin, M. T. (2003) · Free Radical Research · doi:10.1080/1071576021000033112 · Cited by 200
“We have employed highly sensitive methodologies that reduce the S – NO bond from hemoglobin in solutions of I23 , releasing NO gas from the cysteine for ozone-based chemiluminescent detection, and have found the levels of SNO-Hb in vivo to be approximately 50 nM with no artery-to-vein gradient.([16,8,4,17]) These find…”
ResultSelf-citationWeiner, D. L., Hibberd, P. L., Betit, P., Cooper, A. B., Botelho, C. A., & Brugnara, C. (2003) · JAMA · doi:10.1001/jama.289.9.1136 · Cited by 178
“Time from onset of pain to morphine receipt, median (range), h 17 (3-114) 14 (1-83)”
BackgroundSICKLE CELL DISEASE: ROLE OF REACTIVE OXYGEN AND NITROGEN METABOLITES
Wood, K. C., & Granger, D. N. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04639.x · Cited by 167
“The proposed mechanism by which inhaled NO improves vasodilation relies on its substitution for endogenous NO in reactions with free haemoglobin, thereby leaving more endogenous NO available to mediate local vasodilation.(56)”
BackgroundHemoglobin, nitric oxide and molecular mechanisms of hypoxic vasodilation
Allen, B. W., Stamler, J. S., & Piantadosi, C. A. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.08.002 · Cited by 165
Gladwin, M. T., Wang, X., Reiter, C. D., Yang, B. K., Vivas, E. X., Bonaventura, C., & Schechter, A. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203236200 · Cited by 160
Self-citationMcMahon, T. J., & Doctor, A. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200507-066bg · Cited by 87
“Early reports that iNO raised the O2 affinity of sickle cell Hb in vivo (42) in patients with sickle cell disease were later refuted (43).”
BackgroundBrain venular pattern by 7T MRI correlates with memory and haemoglobin in sickle cell anaemia
Novelli, E. M., Elizabeth Sarles, C., Jay Aizenstein, H., Ibrahim, T. S., Butters, M. A., Connelly Ritter, A., Erickson, K. I., & Rosano, C. (2015) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2015.04.005 · Cited by 28
“In adults, however, when the oxygen saturation of venous blood of HbSS patients was directly tested, it was found to be similar to that of HbAA controls, probably because increased blood flow in SCA leads to relatively lower oxygen extraction (Gladwin et al., 1999).”
Metadata
- Authors
- Gladwin, M. T., Schechter, A. N., Shelhamer, J. H., Pannell, L. K., Conway, D. A., Hrinczenko, B. W., Nichols, J. S., Pease-Fye, M. E., Noguchi, C. T., Rodgers, G. P., & Ognibene, F. P.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-10-01
- Volume
- 104
- Issue
- 7
- Pages
- 937-945
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1986059506
- Cited by
- 131
- References
- 5
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.